Диссертация (1139544), страница 41
Текст из файла (страница 41)
С. 29-32.101.Чулков В.С. Оценка показателей суточного мониторированияартериального давления беременных с хронической и гестационнойартериальной гипертензией. Врач-аспирант. 2015. Т. 70. № 3. С. 98-103.102. Шевцова Е.П., Шатилова Ю.А., Булавская Ю.В. Современные подходыв лечении артериальной гипретензии у беременных/ Лекарственныйвестник. 2012.
№ 8. С. 17-21.103. ШевченкоА.В.Рольфизическихтренировокумереннойинтенсивности в коррекции артериального давления и метаболическихпоказателей у больных артериальной гипертонией I степени молодоговозраста с избыточной массой тела: Автореферат дис... канд. мед. наук /защищена 2006.02.22. - 24 с.104.
Юшманова Л.С., Соловьёва Н.А., Совершаева С.Л. Качество жизни взависимости от величины артериального давления и индекса массы телау лиц юношеского возраста. Фундаментальные исследования. 2012. № 92. С. 328-331.245105. Abalos E, Duley L, Steyn DW, et al.
Antihypertensive drug therapy for mildto moderate hypertension during pregnancy. Cochrane Database Syst Rev.2007.V. 1 P. 22- 52.106. Abramson B.L., Melvin R.G. Cardiovascular risk in women: focus onhypertension. Can. J. Cardiol. 2014.-Vol. 30(5).-P. 553-559.107. Aggarwal P.K., Chandel N. The relationship between circulating endothelin1, soluble fms-like tyrosine kinase-1 and soluble endoglin in preeclampsia.//Jurnal Human Hypertension.- 2012.- V. 26(4).- P. 236-241108. Ahima R.S., Lazar M.A.
Physiology. The health risk of obesity-bettermetrics imperative/ Science. -2013.V. 23.Р. 341(6148):856-8109. Ahmad S, Crispi F. Hypoxia induces dilated cardiomyopathy in the chickembryo: mechanism, intervention, and long-term consequences. /PLoSOne.2009.V. 4.Р. 5155110. Airoldi J., Weinstein L.
Clinical significance of proteinuria in pregnancy.Obstet Gynecol Surv. 2007.Vol.62.P.117–124.111. Akolekar R, Etchegaray A, Maternal serum activin a at 11-13 weeks ofgestation in hypertensive disorders of pregnancy. Fetal Diagn Ther.2009.Vol.25(3).P.320-7.112. Al-Nashi M, Eriksson MJ, Östlund E, Bremme K, Kahan T.Cardiac structureand function, and ventricular-arterial interaction 11 years following apregnancy with preeclampsia.J Am Soc Hypertens. 2016.V. 20. pii: S19331711(16)00037-1. doi: 10.1016/j.jash.2016.01.012.113. American College of Obstetricians and Gynecologists Committee onPractice Bulletins–Obstetrics.
ACOG practice bulletin: diagnosis andmanagement of pre-eclampsia and eclampsia: number 33, January 2002.Obstet. Gynecol. 2002.Vol. 99.P. 159–167.114. Ando T., Kaur R., Holmes A.A.Physiological adaptation of the left ventricleduring the second and third trimesters of a healthy pregnancy: a speckletracking echocardiography study.Am J Cardiovasc Dis. 2015.V.1;5(2).P.11926.246115. Andreasen K.R., Andersen M.L. and Schantz A.L. Obesity and pregnancy.Acta. Obstet. Gynecol.
Scand 2004.Vol.83.P.1022–1029.116. Andreto LM, de Souza AI, Figueiroa JN Factors associated with excessivegestational weight gain among patients in prenatal care at a public hospital inRecife, Pernambuco, Brazil Cad Saude Publica. 2006.Vol.11.P.2401-9.117. Aparna Reddy, Sangeeta Suri, Maternal Circulating Levels of Activin A,Inhibin A, sFlt-1 and Endoglin at Parturition in Normal Pregnancy and PreEclampsia December 1, 2008.32p.118.
Ashford E.J., Klimkina O., Hassan Z.U. Transesophageal echocardiographymonitoring in the delivery of a preeclamptic parturient with severe leftventricular noncompaction. J. Clin. Anesth. 2014. V.26(6).P.490-494. doi:10.1016119. Askie LM, Duley L, Henderson-Smart DJ, Stewart LA. PARISCollaborative Group. Antiplatelet agents for prevention of pre-eclampsia. Ameta-analysis of individual patient data. Lancet. 2007.Vol.369.P.1791–1798.120.
August P., and Lindheimer M.D. Pathophysiology of preeclampsia In:Hypertension: Pathophysiology, Diagnosis and Management, edited by LaraghJH, and Brenner BM.. New York: Raven, 1995. P. 2407-2426.121. Ballestri S., Lonardo A., Romagnoli D. Ultrasonographic fatty liverindicator, a novel score which rules out NASH and is correlated withmetabolic parameters in NAFLD.
Liver Int. 2012. V. 32(8).P.1242-52. doi:10.1111/j.1478-3231.2012.02804.x.122. Barros C.G. Effects of socioeconomic change from birth to early adulthoodon height and overweight. 2006.13p.123. Barton J.R., Sibai B.M. Prediction and prevention of recurrent preeclampsia.Obstet Gynecol. 2008.Vol.112.P.359–372.124.
Bellamy L, Casas JP, Hingorami AD, Williams D. Preeclampsia and risk ofcardiovascular disease and cancer in later life: systematic review and metaanalysis. BMJ. 2007.Vol.335P.974–982247125. Bobst S.M., Day M.C., Gilstrap L.C.
3rd, Maternal autoantibodies frompreeclamptic patients activate angiotensin receptors on human mesangial cellsand induce interleukin-6 and plasminogen activator inhibitor-1 secretion. Am.J. Hypertens. 2005. V.18. P.330–336126. Bogaerts A.F., Devlieger R. Anxiety and depressed mood in obese pregnantwomen: a prospective controlled cohort study/ Obes. Facts.
2013.V. 6(2).P.152-164127. Bombrys A.E., Barton J.R., Nowacki E.A., Expectant management of severepreeclampsia at less than 27 weeks’ gestation. Am. J. Obstet. Gynecol.2008.Vol.199.P.247e1–247128. Bosio P.M., McKenna P.J., Conroy R.C. Maternal central hemodynamics inhypertensive disorders or pregnancy. Obstet. Gynecol. 1999.Vol. 94.P.978–984.129. Bouanane S., Benkalfat N.B.
Time course of changes in serumoxidant/antioxidant status in overfed obese rats and their offspring. Clin. Sci.(Lond). 2009.Vol.116(8).P.669-80.130. Bouret S.G., Draper S.J., Simerly R.B. Formation of projection pathwaysfrom the arcuate nucleus of the hypothalamus to hypothalamic regionsimplicated in the neural control of feeding behavior in mice. J. Neurosci.2004.Vol.
24.P. 2797–2805131. Bras P.L., Ricordeau P., Roussille B., Saintoyant V. L'information desmédecins généralistes sur le médicament. Report No RM Inspection généraledes affaires sociales.2007.136 p.132. Braun U., Jacquat D., Steininger K..Ultrasonographic examination of theabdomen of the goat. II. Liver, spleen, urinary tract and greater omentum.Schweiz. Arch. Tierheilkd..
2013. V.155(3).P.185-95. doi: 10.1024/00367281/a000442.133. Brawarsky P., Stotland N.E., Jackson R.A. Pre-pregnancy and pregnancyrelated factors and the risk of excessive or inadequateweight gain. Int J.Gynaecol. Obstet. 2005.Vol.91(2).P.125–31.248134. Brekke H.K., van Odijk J. Predictors and dietary consequences of frequentintake of high-sugar, low-nutrient foods in 1-year-old children participating inthe ABIS study// British Journal Nutrition.2011.
V.1.P.176-181.135. Budak E., Fernбndez Sбnchez M. Interactions of the hormones leptin,ghrelin, adiponectin, resistin, and PYY3-36 with the reproductive system.Fertil Steril. 2006.Vol.85(6).P.1563-81.136. Buhimschi C.S., Magloire L., Funai E., et al. Fractional excretion ofangiogenic factors in women with severe preeclampsia. Obstet. Gynecol.2006.Vol.107(5).P.1103–1113.137. Chambers J.C., Fusi L., Malik I.S. Association of maternal endothelialdysfunction with preeclampsia. JAMA 2001.Vol.285.P.
1607–1612.138. Campoy C., Martn-Bautista E. Study of maternal nutrition and genetic onthe fetal adiposity programming (The PREOBE study)//Nutriciyn Hospitalaria.2012.Vol.23.N6.P.584-590.139. Chandiramani M., Shennan A. Hypertensive disorders of pregnancy: a UKbased perspective// Current Opinion Obstetrics Gynecology. 2010.N20. P.96–101.140. Chappal L.C., St. Seed Enye P., Briley A.L. Adverse perinatal outcomes andrisk factors for preeclampsia in women with chronic hypertension: aprospective study.
Hypertension. 2008.Vol.51.P.1002–1009.141. Chen F.H.. Antioxidant, antiproliferative, and pro-apoptotic activities of asaponin extract derived from the roots of Panax notoginseng (Burk.). J MedFood. 2012 .V.15(4).P. 350-359142. Cindrova-Davies T. The therapeutic potential of antioxidants, ERchaperones, NO and H2S donors, and statins for treatment of preeclampsia/Front Pharmacol. 2014.V.
27;5. P.119143. Clark M.K., Dhillon J.S, Sowers M and Nichols S Weight, fat mass andcentraldistributionmedroxyprogesteroneoffatacetate2005.Vol.29.P.1252–1258.increaseforwhenwomencontraception.Int.usedepot-J.Obes249144. Classification of Functioning, Disability and Health: ICF (ВОЗ, 2001)145. Conde-Agudelo A, Villar J, Lindheimer M. World Health Organization.Systematic review of screening tests for preeclampsia. Obstet Gynecol.2004.Vol.104.P.1367–1391.146. Daher C.H., Gomes A.C., Kobayashi S. Ultrasonographic study and Dopplerflow velocimetry of maternal kidneys and liver in low-risk pregnancy.
RadiolBras. 2015. V.48(3):135-42. doi: 10.1590/0100-3984.2013.1822.147. da Silva A.A., do Carmo J.M., Kanyicska B. Endogenous melanocortinsystem activity contributes to the elevated arterial pressure in spontaneouslyhypertensive rats. Hypertension. 2008.Vol.51.P.884–890.148. De Cristofaro P, Pompilii SNutritional dynamic monitoring duringpregnancy: a personalized intervention of prevention Recenti Prog Med.2008.Vol.99(6).P.302-305.149.
Delmis J. Hypertension in pregnancy Lijec Vjesn. 2006 Nov-Dec;128(1112):357-68.150. Demirtaş S, Can M, Yarpuzlu A. Hepatorenal syndrome.Clin. Chem. Lab.Med. 2006. V.44(4). P.379-86.151. de Moura EG, Neonatal programming of body weight regulation andenergetic metabolism. Biosci Rep.2005.Vol.25(3-4).P.251-69.152. DennisA.T.Transthoracicechocardiographyinwomenwithpreeclampsia.Curr. Opin. Anaesthesiol.
2015 Jun;28(3):254-60. doi: 10.1097153. De Vivo A, Baviera G., Endoglin, PlGF and sFlt-1 as markers for predictingpre-eclampsia Acta Obstet Gynecol Scand.2008.Vol.87(8).P.837-42.154. Djiane J, Attig L. Role of leptin during perinatal metabolic programmingand obesity. J Physiol Pharmacol. 2008.Vol.59.P.55-63.155. Donahue SM, Rifas-Shiman SL Associations of maternal prenatal dietaryintake of n-3 and n-6 fatty acids with maternal and umbilical cord bloodlevels. Prostaglandins Leukot Essent Fatty Acids. 2009.Vol.;80(5-6)P.289-96.250156. Duckitt K, Harrington D.
Risk factors for pre-eclampsia at antenatalbooking: systematic review of controlled studies. BMJ. 2005.Vol.330.P.565–572.157. Duley L, Henderson-Smart DJ, Meher S, King JF. Antiplatelet agents forpreventing pre-eclampsia and its complications (review). Cochrane DatabaseSyst Rev. 2007.Vol. 2.P. 004659.158. Dulloo AG. A role for suppressed skeletal muscle thermogenesis inpathways from weight fluctuations to the insulin resistance syndrome. ActaPhysiol Scand.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
